PATENT CLAIM ANALYSIS

Application Number: 16151012
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["424", "133100"]

Abstract:
The invention provides humanized antibodies that specifically bind to BCMA. The antibodies are useful for treatment and diagnoses of various cancers and immune disorders as well as detecting BCMA.

Claim (Index 5):
The antibody of  claim 1 , wherein positions H20, H48, H69, H71, H73, H76, H80, H88, H91 and H93 are occupied by L, I, M, A, K, N, V, A, F, and T respectively, and positions L46, L48 and L87 are occupied by V, V and F respectively.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 97.0
- Lexical Diversity: 1.24
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14948183', '13990778', '15587255', '15199236', '15125570']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7542578779298074
- 35 USC 102 Novelty (BERT): 0.5482252844289499
- Combined Prediction Score: 0.7336546185797217
- Mean Citation Score: 394.93259600000016
- Max Citation Score: 407.57016
- Similarity Product: 285.4685027506256

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test